Le Lézard
Classified in: Health
Subject: TDS

IFF to Showcase Science-backed Low Nitrite Excipients at Excipient World 2024


Experts will present risk assessment strategies for nitrite detection and quality evaluation to promote safer pharmaceutical formulations with better patient outcomes 

NEW YORK, April 29, 2024 /PRNewswire/ -- IFF's Pharma Solutions division will highlight innovative solutions to help pharmaceutical manufacturers seeking science-backed excipients with effective strategies to support their nitrosamine risk mitigation plans at Excipient World 2024, May 13-15, Gaylord Palms Resort and Convention Center, Kissimmee, Florida at booth 214.

Nitrosamine risk assessment and control have become an integral part of pharmaceutical drug product development and quality evaluation. With more than 70 years of expertise in cellulosic excipients, IFF's pioneering, leading brands ? Avicel® PH LN, a robust low nitrite microcrystalline cellulose (MCC) and METHOCELtm range of water-soluble cellulose ethers are proven effective in reducing nitrosamines in model formulations.

"As the pharmaceutical landscape evolves, it is important to address and solve any challenges associated with nitrosamine risk," said Angela Strzelecki, president, Pharma Solutions, IFF. "Collaborating with an excipient manufacturer with vital expertise, and robust formulation and analytical capabilities enables drug developers to confidently and efficiently incorporate low nitrite excipients into their formulations."

Attendees will have the opportunity to meet with IFF experts and discuss areas such as regulatory compliance, quality, consistency, product innovation, and how the Company's state-of-the-art excipients can help elevate drug formulations, optimize drug delivery, and ultimately contribute to patient well-being. 

IFF will share nitrosamine analytical insights and the latest scientific advancements during the following informative sessions:

Register here to schedule a meeting at Excipient World 2024.

Welcome to IFF

At IFF (NYSE: IFF), an industry leader in food, beverage, health, biosciences and scent, science and creativity meet to create essential solutions for a better world ? from global icons to unexpected innovations and experiences. With the beauty of art and the precision of science, we are an international collective of thinkers who partner with customers to bring scents, tastes, experiences, ingredients and solutions for products the world craves. Together, we will do more good for people and planet.  Learn more at iff.comTwitter , FacebookInstagram, and LinkedIn

©2024 International Flavors & Fragrances Inc. (IFF). IFF, the IFF Logo, and all trademarks and service marks denoted with tm, SM or ® are owned by IFF or affiliates of IFF unless otherwise noted. All Rights Reserved.

Contact:
Lisa Luke 
Global Communications Director
1 302-927-9234
[email protected]

SOURCE IFF


These press releases may also interest you

at 18:00
bioLytical Laboratories Inc. announced today the immediate availability of its INSTI® HCV Antibody Test in the Australian market.  The INSTI Hepatitis C (HCV) Antibody Test is now included in the Australian Register of Therapeutic Goods (ARTG...

at 17:20
The Phase IIa COURSE trial was a proof-of-concept study in people with moderate to very severe chronic obstructive pulmonary disease (COPD) with a broad range of blood eosinophil counts (BEC) and irrespective of emphysema, chronic bronchitis or...

at 14:15
Endeavor BioMedicines, a clinical-stage biotechnology company developing medicines with the potential to deliver transformational clinical benefits to patients with life-threatening diseases, announced results from a completed Phase 2a clinical trial...

at 12:20
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, presented a poster at the American Thoracic Society (ATS) 2024 International Conference that is taking place May 17-22, 2024, in San Diego,...

at 12:18
Product: Kalihim (Philippine Bread Roll) Issue: Food - Allergen - Egg Distribution: British Columbia See the affected products and product photos for this recall SOURCE Canadian Food Inspection Agency (CFIA)

at 11:10
Orion Health, a global leader in digital health solutions, announced today that it has been awarded partner status by Panda Health for its Orchestral Health Intelligence Platform, one of three pillars of the Unified Healthcare Platform. Panda Health...



News published on and distributed by: